Moreover, increases in TRPM4 mRNA have been observed in prostate cancer [74–76], in B-cell non-Hodgkin lymphoma and in a human cervical-uterine tumor samples and cervical-uterine cancer derived cell lines [77,78]. This evidence concerns the gene TRPM4 and uterine cancer.